Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214454) titled 'TCDS for the Treatment of Chronic Migraine' on Sept. 30.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Device Feasibility. Masking: None (Open Label).
Primary Sponsor: University College, London
Condition:
Chronic Migraine Headache
Transcranial Direct Current Stimulation
Intervention:
Device: Transcranial direct current stimulation (Nettle device) 2mA stimulation for 20 minutes per day
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 1, 2025
Target Sample Size: 20
To know more, visit https://clinic...